In This Issue

This week we publish the first of four stories of this year's Heroes in the Struggle Awardees, starting with our old friend Greg Millett, now at amfAR. (Note: a photo caption in the previous version of this issue mistakenly identifed him as still being at ONAP).

Research shows that the new Hep C treatments are working well among African Americans, who are affected disproportionately by HCV. These treatments work faster, people tolerate them better and they have significantly higher cure rates than the previous treatments did. AIDS.gov explains.

As celebrities like Janet Mock and, more recently, Bruce Jenner raise the public's awareness of transgender people, we run the first in a two-part series about the health challenges that they often face, particularly African Americans. Candace Y.A. Montague reports.

NIH is running a new heart-health study to evaluate whether a particular statin can reduce the risk of cardiovascular disease among PLWHAs on ARVs. Read on to learn more and how you can enroll.

Finally, the Supreme Court will soon rule in a major case about health insurance subsidies. What exactly is at stake? Our friends at Kaiser Health News fill us in.

Yours in the struggle,

Phill